Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus.

Vuitton L, Peyrin-Biroulet L, Colombel JF, Pariente B, Pineton de Chambrun G, Walsh AJ, Panes J, Travis SP, Mary JY, Marteau P.
Aliment Pharmacol Ther. 2017 Mar;45(6):801-813. doi: 10.1111/apt.13948. Epub 2017 Jan 23
PMID: 28112419 [PubMed - indexed for MEDLINE]

Ulcerative colitis

Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF
Lancet. 2017 Apr 29;389(10080):1756-1770. doi: 10.1016/S0140-6736(16)32126-2. Epub 2016 Dec 1
PMID: 27914657 [PubMed - indexed for MEDLINE]

AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis.

Feuerstein JD, Isaacs KL, Schneider Y, Siddique SM, Falck-Ytter Y, Singh S; AGA Institute Clinical Guidelines Committee.
Gastroenterology. 2020 Apr;158(5):1450-1461. doi: 10.1053/j.gastro.2020.01.006. Epub 2020 Jan 13.
PMID: 31945371 Free PMC article. No abstract available.

Management of ulcerative colitis: summary of updated NICE guidance.

Abdulrazeg O, Li B, Epstein J; Guideline Committee.
BMJ. 2019 Oct 28;367:l5897. doi: 10.1136/bmj.l5897.
PMID: 31658951 No abstract available.

Is Endoscopic Remission in Ulcerative Colitis Still Good Enough?

Bhattacharya S, Cross RK.
Inflamm Bowel Dis. 2019 Oct 18;25(11):1729-1730. doi: 10.1093/ibd/izz177.
PMID: 31412124

An approach to acute severe ulcerative colitis.

Sedano R, Quera R, Simian D, Yarur AJ.
Expert Rev Gastroenterol Hepatol. 2019 Oct;13(10):943-955. doi: 10.1080/17474124.2019.1681974. Epub 2019 Oct 30.
PMID: 31648574 Review.

Biologics beyond Anti-TNF Agents for Ulcerative Colitis - Efficacy, Safety, and Cost?

Farrell RJ.
N Engl J Med. 2019 Sep 26;381(13):1279-1281. doi: 10.1056/NEJMe1910742.
PMID: 31553842.

Maneuvering Clinical Pathways for Ulcerative Colitis.

Johnson CM, Linzay CD, Dassopoulos T.
Curr Gastroenterol Rep. 2019 Sep 5;21(10):52. doi: 10.1007/s11894-019-0716-3.
PMID: 31486929

Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis.

Sandborn WJ, Baert F, Danese S, Krznarić Ž, Kobayashi T, Yao X, Chen J, Rosario M, Bhatia S, Kisfalvi K, D'Haens G, Vermeire S.
Gastroenterology. 2020 Feb;158(3):562-572.e12. doi: 10.1053/j.gastro.2019.08.027. Epub 2019 Aug 28.
PMID: 31470005 Clinical Trial.

Prospective cohort study of appendicectomy for treatment of therapy-refractory ulcerative colitis.

Stellingwerf ME, Sahami S, Winter DC, Martin ST, D'Haens GR, Cullen G, Doherty GA, Mulcahy H, Bemelman WA, Buskens CJ.
Br J Surg. 2019 Nov;106(12):1697-1704. doi: 10.1002/bjs.11259. Epub 2019 Aug 8.
PMID: 31393608 Clinical Trial.

New markers in ulcerative colitis.

Nakov R
Clin Chim Acta. 2019 Oct;497:141-146. doi: 10.1016/j.cca.2019.07.033. Epub 2019 Jul 27.
PMID: 31361991

A comprehensive review and update on ulcerative colitis.

Gajendran M, Loganathan P, Jimenez G, Catinella AP, Ng N, Umapathy C, Ziade N, Hashash JG.
Dis Mon. 2019 Dec;65(12):100851. doi: 10.1016/j.disamonth.2019.02.004. Epub 2019 Mar 2.
PMID: 30837080

Induction and maintenance treatment of inflammatory bowel disease: A comprehensive review.

Jeong DY, Kim S, Son MJ, Son CY, Kim JY, Kronbichler A, Lee KH, Shin JI.
Autoimmun Rev. 2019 May;18(5):439-454. doi: 10.1016/j.autrev.2019.03.002. Epub 2019 Mar 4. Review.
PMID: 30844556 [PubMed - indexed for MEDLINE]

Ulcerative colitis (UC) and Crohn's disease (CD) are the two major types of inflammatory bowel disease (IBD)....

Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial.

JCostello SP, Hughes PA, Waters O, Bryant RV, Vincent AD, Blatchford P, Katsikeros R, Makanyanga J, Campaniello MA, Mavrangelos C, Rosewarne CP, Bickley C, Peters C, Schoeman MN, Conlon MA, Roberts-Thomson IC, Andrews JM.
JAMA. 2019 Jan 15;321(2):156-164. doi: 10.1001/jama.2018.20046.
PMID: 30644982 [PubMed - indexed for MEDLINE]

High-intensity, aerobically prepared fecal microbiota transplantation (FMT) has demonstrated efficacy in treating active ulcerative colitis (UC).....

Fecal transplantation for treatment of inflammatory bowel disease.

Imdad A, Nicholson MR, Tanner-Smith EE, Zackular JP, Gomez-Duarte OG, Beaulieu DB, Acra S
Cochrane Database Syst Rev. 2018 Nov 13;11:CD012774. doi: 10.1002/14651858.CD012774.pub2
PMID: 30480772 [PubMed - indexed for MEDLINE]

Inflammatory bowel disease (IBD) is a chronic, relapsing disease of the gastrointestinal.....

Enteral Nutrition in the Management of Pediatric and Adult Crohn's Disease.

Hansen T, Duerksen DR.
Nutrients. 2018 Apr 26;10(5). pii: E537. doi: 10.3390/nu10050537.
PMID: 29701656 [PubMed - indexed for MEDLINE]

Genetic and environmental factors are thought to profoundly influence the pathophysiology.....

Updated review on immune factors in pathogenesis of Crohn's disease.

Li N, Shi RH.
World J Gastroenterol. 2018 Jan 7;24(1):15-22. doi: 10.3748/wjg.v24.i1.15.
PMID: 29358878 [PubMed - indexed for MEDLINE]

Although the incidence of Crohn's disease (CD) in China is not as high as that in European....

Exclusive Enteral Nutrition Induces Remission in Pediatric Crohn's Disease via Modulation of the Gut Microbiota.

Gong D, Yu X, Wang L, Kong L, Gong X, Dong Q.
Biomed Res Int. 2017;2017:8102589. doi: 10.1155/2017/8102589. Epub 2017 Oct 16.
PMID: 29124070 [PubMed - indexed for MEDLINE]

(EEN) has been proven to be effective and safe in treating pediatric....

Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis.

Narula N, Kassam Z, Yuan Y, Colombel JF, Ponsioen C, Reinisch W, Moayyedi P.
Inflamm Bowel Dis. 2017 Oct;23(10):1702-1709. doi: 10.1097/MIB.0000000000001228.
PMID: 28906291 [PubMed - indexed for MEDLINE]

Changes in the colonic microbiota may play a role in the pathogenesis....

Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.

Paramsothy S, Paramsothy R, Rubin DT, Kamm MA, Kaakoush NO, Mitchell HM, Castaño-Rodríguez N.
J Crohns Colitis. 2017 Oct 1;11(10):1180-1199. doi: 10.1093/ecco-jcc/jjx063.
PMID: 28486648 [PubMed - indexed for MEDLINE]

[FMT] has been investigated as a potential treatment for inflammatory....

A Microbiome Foundation for the Study of Crohn's Disease.

Gevers D, Kugathasan S, Knights D, Kostic AD, Knight R, Xavier RJ.
Cell Host Microbe. 2017 Mar 8;21(3):301-304. doi: 10.1016/j.chom.2017.02.012.
PMID: 28279336 [PubMed - indexed for MEDLINE]

Our 2014 study published in Cell Host & Microbe....

Natural history and long-term clinical course of Crohn's disease.

Freeman HJ.
World J Gastroenterol. 2014 Jan 7;20(1):31-6. doi: 10.3748/wjg.v20.i1.31. Review.
PMID: 24415855 [PubMed - indexed for MEDLINE]

Crohn's disease is a chronic inflammatory disease process involving different sites in the gastrointestinal tract....

Crohn's disease.

Baumgart DC, Sandborn WJ..
Lancet. 2012 Nov 3;380(9853):1590-605. doi: 10.1016/S0140-6736(12)60026-9. Epub 2012 Aug 20. Review. Erratum in: Lancet. 2013 Jan 19;381(9862):204.
PMID: 22914295 [PubMed - indexed for MEDLINE]

Crohn's disease is a relapsing systemic inflammatory disease, mainly affecting the gastrointestinal tract....

The Artificial Sweetener Splenda Promotes Gut

15 March 2018

The Artificial Sweetener Splenda Promotes Gut Proteobacteria, Dysbiosis, and Myeloperoxidase Reactivity in Crohn’s Disease–Like Ileitis....

The Influence of Antidepressants on the Disease Course Among Patients

14 December 2018

The Influence of Antidepressants on the Disease Course Among Patients With Crohn’s Disease and Ulcerative Colitis—A Danish Nationwide Register–Based Cohort Study...